Beyond T Cells: Understanding the Role of PD-1/PD-L1 in Tumor-Associated Macrophages

J Immunol Res. 2019 Nov 4:2019:1919082. doi: 10.1155/2019/1919082. eCollection 2019.

Abstract

Programmed cell death protein 1 (PD-1) and its ligand PD-L1 have attracted wide attention from researchers in the field of immunotherapy. PD-1/PD-L1 have been shown to exist in many types of cells in addition to T lymphocytes, and studies have accordingly extended from their suppressive effect on T cell activation and function to examining their role in other cells. In this review, we summarize recent research on PD-1/PD-L1 in macrophages, with the aim of furthering our understanding of PD-1/PD-L1 and their detailed roles in macrophages. This information may provide additional insights for researchers, enrich the basic theory of anti-PD-1/PD-L1 immunotherapy, and thus ultimately benefit more patients.

Publication types

  • Review

MeSH terms

  • Animals
  • B7-H1 Antigen / metabolism*
  • Disease Susceptibility
  • Humans
  • Macrophages / immunology*
  • Macrophages / metabolism*
  • Neoplasms / etiology*
  • Neoplasms / metabolism*
  • Neoplasms / pathology
  • Programmed Cell Death 1 Receptor / metabolism*
  • T-Lymphocytes / immunology*
  • T-Lymphocytes / metabolism*
  • Tumor Microenvironment

Substances

  • B7-H1 Antigen
  • CD274 protein, human
  • Programmed Cell Death 1 Receptor